Key Points
- CEO Saumya Sutaria sold 50,000 Tenet Healthcare shares at an average price of $278.71, generating $13.94 million. The sale reduced her direct ownership by 9.37% to 483,564 shares.
- Tenet reported strong quarterly results, with EPS of $6.12 versus the $4.26 consensus estimate and revenue of $6.04 billion, up 6.8% year over year. The company set fiscal 2026 EPS guidance at $20.30–$21.69.
- Wall Street remains broadly bullish: 19 analysts rate the stock a Buy, one rates it a Hold, and the average price target is $273. Institutional investors own 95.44% of Tenet’s shares.
Tenet Healthcare Corporation (NYSE:THC - Get Free Report) Director Cecil Haney sold 1,300 shares of the stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $278.03, for a total transaction of $361,439.00. Following the sale, the director owned 12,553 shares of the company's stock, valued at approximately $3,490,110.59. This represents a 9.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Tenet Healthcare Stock Performance
Shares of THC stock opened at $274.06 on Thursday. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The stock has a fifty day moving average of $226.21 and a 200 day moving average of $208.66. The firm has a market capitalization of $22.07 billion, a price-to-earnings ratio of 10.57, a PEG ratio of 1.04 and a beta of 1.23. Tenet Healthcare Corporation has a 52 week low of $157.58 and a 52 week high of $283.05.
Tenet Healthcare (NYSE:THC - Get Free Report) last posted its earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, topping analysts' consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The firm had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. During the same quarter in the prior year, the business earned $4.02 EPS. The business's revenue for the quarter was up 6.8% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 20.98 earnings per share for the current year.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on THC. Robert W. Baird increased their price target on Tenet Healthcare from $210.00 to $280.00 and gave the stock a "neutral" rating in a research note on Tuesday, July 28th. Royal Bank Of Canada increased their target price on Tenet Healthcare from $236.00 to $283.00 and gave the stock an "outperform" rating in a research report on Monday, July 27th. Raymond James Financial restated an "outperform" rating and issued a $285.00 price target on shares of Tenet Healthcare in a research note on Friday, August 14th. The Goldman Sachs Group restated a "buy" rating and set a $305.00 target price on shares of Tenet Healthcare in a research report on Tuesday, July 28th. Finally, Mizuho set a $290.00 price objective on shares of Tenet Healthcare in a research report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $273.00.
View Our Latest Research Report on THC
Institutional Investors Weigh In On Tenet Healthcare
Institutional investors have recently made changes to their positions in the company. Triumph Capital Management purchased a new stake in shares of Tenet Healthcare in the third quarter worth approximately $25,000. Activest Wealth Management purchased a new stake in Tenet Healthcare during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new stake in shares of Tenet Healthcare during the fourth quarter worth about $29,000. Canada Pension Plan Investment Board acquired a new position in Tenet Healthcare during the 2nd quarter valued at approximately $35,000. Finally, Trust Co. of Vermont purchased a new stake in shares of Tenet Healthcare during the second quarter valued at $37,000. Institutional investors own 95.44% of the company's stock.
About Tenet Healthcare
(
Get Free Report)
Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
